IN8bio Inc

NASDAQ:INAB  
2.48
+0.22 (+9.74%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

IN8bio Inc Stock, NASDAQ:INAB

350 5th Avenue, Suite 5330, New York, New York 10118
United States of America
Phone: +1.646.600.6438
Number of Employees: 19

Description

IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.